# Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients

> **NCT00472082** · PHASE1,PHASE2 · TERMINATED · sponsor: **Emory University** · enrollment: 5 (actual)

## Conditions studied

- Kidney Transplantation
- Chronic Kidney Failure

## Interventions

- **DRUG:** efalizumab

## Key facts

- **NCT ID:** NCT00472082
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** This study was terminated at the request of the drug manufacturer.
- **Last updated:** 2014-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472082, "Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00472082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*